Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O’Sullivan MJ, Rossouw JE, Anderson GL (2008) Conjugated

equine estrogens and breast cancer risk Momelotinib in the Women’s Health Initiative clinical trial and observational study. Am J Epidemiol 167:1407–1415PubMedCrossRef 21. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O’Sullivan MJ, Rossouw JE, Anderson GL (2008) Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol 167:1207–1216PubMedCrossRef 22. Prentice RL, Pettinger M, Beresford SA, Wactawski-Wende J, Hubbell FA, Stefanick ML, Chlebowski RT (2009) Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women’s MK-4827 Health Initiative clinical trial and observational study. Cancer Epidemiol Biomarkers Prev 18:1531–1537PubMedCrossRef

23. Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE (2009) Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol 170:12–23PubMedCrossRef 24. Women’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative Clinical Trial and

Observational these Study. Control Clin Trials 19:61–109CrossRef 25. Jackson RD, LaCroix AZ, Cauley JA, McGowan J (2003) The Women’s Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol 13:S98–S106PubMedCrossRef 26. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The Women’s Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–S121PubMedCrossRef 27. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S, Morbidity WHI, Committee M (2003) Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Ann Epidemiol 13:S122–S128PubMedCrossRef 28. Patterson RE, Levy L, Tinker LF, Kristal AR (1999) Evaluation of a simplified vitamin supplement inventory developed for the Women’s Health Initiative. Public Health Nutr 2:273–276PubMedCrossRef 29. Patterson RE, Kristal AR, Levy L, McLerran D, White E (1998) Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol 148:643–649PubMedCrossRef 30. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, BIBW2992 nmr Agurs-Collins T (1999) Measurement characteristics of the Women’s Health Initiative food frequency questionnaire. Ann Epidemiol 9:178–187PubMedCrossRef 31.